[Adequate restitution in primary hypothyroidism depending on levothyroxine formulations].

Background: The prevalence of primary hypothyroidism (PH) is around 3.8%-4.6% in general population.

SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study.

Background: Type 2 diabetes mellitus (T2DM) is a progressive chronic disease associated with severe microvascular and macrovascular complications. Our aim is to assess the real world effectiveness of SGT" inhibitors in achieving metabolic therapeutic goals.

Methods: A retrospective, observational study.